A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...
President Joe Biden's proposal to have GLP-1 weight-loss drugs such as Wegovy, Ozempic, Zepbound and Mounjaro covered by Medicare and Medicaid would help tackle the public-health crisis of obesity, ...